Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
OVERLAP
14%
OVERLAP
BY WEIGHT
10
# OF OVERLAPPING
HOLDINGS
BBP
67
HOLDINGS
16%
ALSO IN XPH
XPH
55
HOLDINGS
20%
ALSO IN BBP
SECTOR DRIFT (BBP minus XPH)
OVERLAPPING HOLDINGS
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in BBP |
Weight in XPH |
Overlap | |
|---|---|---|---|---|
 |
AXSOME THERAPEUTICS, INC. | 1.9% | 2.2% | 1.9% |
|
LIGAND PHARMACEUTICALS-CL B | 1.6% | 1.9% | 1.6% |
|
ESPERION THERAPEUTICS INC | 1.5% | 1.6% | 1.5% |
|
TARSUS PHARMACEUTICALS, INC. | 1.6% | 1.5% | 1.5% |
|
CRINETICS PHARMACEUTICALS INC | 1.4% | 1.7% | 1.4% |
BBP Overweight Relative to XPH
|
DYNAVAX TECHNOLOGIES CORP | 2.2% |
|
AMICUS THERAPEUTICS INC | 2.1% |
|
IOVANCE BIOTHERAPEUTICS INC | 1.9% |
|
MIRUM PHARMACEUTICALS, INC. | 1.9% |
|
DAY ONE BIOPHARMACEUTICALS, INC. | 1.7% |
|
BIOMARIN PHARMACEUTICAL INC | 1.7% |
|
TRAVERE THERAPEUTICS, INC. | 1.7% |
|
HALOZYME THERAPEUTICS INC | 1.7% |
|
EXELIXIS INC | 1.7% |
|
REGENERON PHARMACEUTICALS | 1.6% |
BBP Underweight Relative to XPH
|
DEFINIUM THERAPEUTICS INC | -2.5% |
|
LIQUIDIA TECHNOLOGIES, INC. | -2.4% |
|
VIATRIS, INC. | -2.3% |
|
MERCK & CO. INC. | -2.3% |
|
PHIBRO ANIMAL HEALTH CORP-A | -2.3% |
|
EDGEWISE THERAPEUTICS, INC. | -2.2% |
|
BRISTOL-MYERS SQUIBB CO | -2.2% |
|
AMNEAL PHARMACEUTICALS, INC. CLASS A | -2.2% |
|
ELANCO ANIMAL HEALTH, INC. | -2.2% |
|
ROYALTY PHARMA PLC CLASS A | -2.1% |